RhumbLine Advisers’s Audentes Therapeutics, Inc BOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-65,035
| Closed | -$3.89M | – | 2963 |
|
|
2019
Q4 | $3.89M | Buy |
65,035
+3,984
| +7% | +$238K | 0.01% | 1411 |
|
|
2019
Q3 | $1.72M | Buy |
61,051
+1,070
| +2% | +$30.1K | ﹤0.01% | 1822 |
|
|
2019
Q2 | $2.27M | Buy |
59,981
+10,633
| +22% | +$403K | ﹤0.01% | 1664 |
|
|
2019
Q1 | $1.93M | Buy |
49,348
+3,198
| +7% | +$125K | ﹤0.01% | 1740 |
|
|
2018
Q4 | $984K | Buy |
46,150
+16,632
| +56% | +$355K | ﹤0.01% | 2023 |
|
|
2018
Q3 | $1.17M | Sell |
29,518
-1,591
| -5% | -$63K | ﹤0.01% | 1935 |
|
|
2018
Q2 | $1.19M | Buy |
31,109
+14,101
| +83% | +$539K | ﹤0.01% | 1934 |
|
|
2018
Q1 | $511K | Buy |
17,008
+3,657
| +27% | +$110K | ﹤0.01% | 2203 |
|
|
2017
Q4 | $417K | Hold |
13,351
| – | – | ﹤0.01% | 2312 |
|
|
2017
Q3 | $374K | Buy |
13,351
+170
| +1% | +$4.76K | ﹤0.01% | 2456 |
|
|
2017
Q2 | $252K | Buy |
+13,181
| New | +$252K | ﹤0.01% | 2645 |
|